← All stocks

GeneDx Holdings Corp.

WGS Net buying

CIK 0001818331 #1896 in the set updated 17 Sep 2026

Bought (12 mo)

$106.60M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$22.53M

$1.90M on a plan · $11.68M straight out of an exercise

Sold at will

$8.94M

26 of 113 sales

Net

+$84.07M

+$97.66M against sales at will

By person

11 insiders · 147 transactions

12.6×

Katherine Stueland holds 12.6 times base salary in stock. $9.03M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $84.22, the price Class A Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Meister Keith A.

Director

$74.03M (29)

—

+$74.03M

4,808,275

16.12%

$404.94M

+93.8%

Casdin Capital, LLC entity

Director

$32.57M (5)

—

+$32.57M

3,707,164

12.43%

$312.21M

+5.7%

Stueland Katherine

CHIEF EXECUTIVE OFFICER

—

$11.87M (42) scheduled

−$11.87M

107,227

0.3596%

$9.03M

+3.4%

RUCH JOSHUA

Director

—

$6.09M (15)

−$6.09M

153,382

0.5143%

$12.92M

−7.6%

Feeley Kevin

CHIEF FINANCIAL OFFICER

—

$3.71M (44) scheduled

−$3.71M

41,476

0.1391%

$3.49M

−53.7%

Dechairo Bryan

Chief Operating Officer

—

$850.56K (12) scheduled

−$850.56K

0.0000%

$0.00

—

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

10% owner

—

2,719,692

9.12%

$229.05M

−27.1%

Ryan Jason

Director

—

118,764

0.3982%

$10.00M

−64.0%

PFENNIGER RICHARD C JR

Director

—

45,082

0.1512%

$3.80M

+63.0%

Leproust Emily M.

Director

—

24,852

0.0833%

$2.09M

+197.6%

Casdin Eli

Director

—

24,093

0.0808%

$2.03M

+217.3%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Dechairo Bryan

4 Feb 2026

Chief Operating Officer

Sold on a plan

100

$91.92

$9.19K

Dechairo Bryan

4 Feb 2026

Chief Operating Officer

Sold on a plan

100

$90.45

$9.05K

Dechairo Bryan

4 Feb 2026

Chief Operating Officer

Sold on a plan

328

$88.66

$29.08K

Dechairo Bryan

4 Feb 2026

Chief Operating Officer

Sold on a plan

1,572

$87.66

$137.80K

Dechairo Bryan

4 Feb 2026

Chief Operating Officer

Sold on a plan

623

$86.35

$53.80K

Dechairo Bryan

4 Feb 2026

Chief Operating Officer

Sold on a plan

1,034

$84.93

$87.82K

Dechairo Bryan

4 Feb 2026

Chief Operating Officer

Sold on a plan

1,425

$83.83

$119.46K

Dechairo Bryan

4 Feb 2026

Chief Operating Officer

Sold on a plan

779

$83.04

$64.68K

Stueland Katherine

30 Sep 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

136

$113.68

$15.46K

Stueland Katherine

30 Sep 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

645

$111.84

$72.13K

Stueland Katherine

30 Sep 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

200

$110.23

$22.05K

Stueland Katherine

30 Sep 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

554

$109.13

$60.46K

Stueland Katherine

30 Sep 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

5,163

$108.55

$560.46K

Stueland Katherine

30 Sep 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

4,462

$107.61

$480.16K

Stueland Katherine

30 Sep 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

1,092

$106.69

$116.51K

Stueland Katherine

30 Sep 2025

CHIEF EXECUTIVE OFFICER

Sold on a plan

606

$105.10

$63.69K

Show all 147 transactions →

GeneDx Holdings Corp.

By person

Individual transactions

What was left out